The 5th Annual Cell Engager Summit is back in Boston, MA this year – the only industry-led meeting bringing together 100+ pharma and biotech leaders will assemble for a 3-day agenda including 4 unique pre-conference workshops to delve into the biggest challenges cell engager therapeutics face. Breaking into the solid tumor, preventing CRS and maximizing the quality of insights we gain from preclinical modeling.
- Gain first-hand knowledge of the difficulties of developing kinase inhibitors to improve selectivity, cross the blood-brain barrier, and combat resistance
- Utilize cutting-edge platforms and technologies to maximise target validation and precisely predict off-target impacts to save time and costs
- Establish long-lasting relationships by speaking with top pharma and biotech firms that are working on kinase inhibitor medicines and looking for the best-in-class solutions directly
Join your colleagues from the likes of Apexigen, Regeneron Pharmaceuticals, Genentech, Roche, Amgen, Boehringer Ingelheim and many more at the most comprehensive cell engager event, leaving no stone unturned, this highly focussed meeting covers everything translational and clinical in greater depth and detail than any before it.